Roger S. Blumenthal, MD

Atrial fibrillation is a common arrhythmia that increases risk for stroke, HF and dementia. Although AF risk increases with age, it can also occur in young people with normal hearts, sometimes called “lone AF.”

Recently, there have been a number of cases in which high-profile athletes have had sudden cardiac arrest due to a variety of causes.

The South Asian population in the U.S. is one of the fastest-growing minority ethnic groups, and these individuals are a particularly higher-risk population.

In the past decade, there have been major advances in lipid-lowering therapeutics, and another was made apparent in March at the American College of Cardiology Scientific Session.

CHICAGO — In the PROMINENT trial, pemafibrate lowered triglycerides but did not cut the incidence of CV events compared with placebo in patients with type 2 diabetes and mixed dyslipidemia.

LDL reduction is the major focus in the primary and secondary prevention of atherosclerotic CVD.

The U.S. Preventive Services Task Force in August published a statement regarding the initiation of statin therapy for the primary prevention of atherosclerotic CVD.

The deleterious effects of pollution on human CV health have garnered attention from both governmental agencies and nongovernmental researchers interested in understanding their pathophysiology and epidemiologic implications.

CVD leads to approximately 40% to 50% of deaths in patients with advanced chronic kidney disease or end-stage renal disease, so CV risk assessment of recipients and donors is an important part of the kidney transplantation process.

The American Heart Association and American College of Cardiology recently released the first chest pain guideline written under their purview.